Mark C Zobeck (Mark Zobeck)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 15

Top Topics

Oxide Nanoparticles

Allogeneic Hematopoietic Stem Cell Transplantation

Acute Lymphoblastic Leukemia

Top Venues

Pediatric blood & cancer

Pharmacotherapy

medRxiv : the preprint server for health sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Rachel D Harris, Olga A Taylor, Kimberly P Raghubar, Maria Monica J Gramatges, Mark C Zobeck, M Monica Gramatges, Karen R Rabin, Michael E Scheurer, Austin L Brown
Episodes of acute methotrexate-related neurotoxicity linked to compromised long-term neurocognitive function. Pediatric blood & cancer 71 (9) (2024)
Rachel D Harris, Olga A Taylor, Kimberly P Raghubar, Maria Monica J Gramatges, Mark C Zobeck, M Monica Gramatges, Karen R Rabin, Michael E Scheurer, Austin L Brown
Episodes of acute methotrexate-related neurotoxicity linked to compromised long-term neurocognitive function. Pediatric blood & cancer 71 (9) (2024)
Mark C Zobeck, Javed Khan, Rajkumar Venkatramani, M Fatih Okcu, Michael E Scheurer, Philip J Lupo
Improving Individualized Rhabdomyosarcoma Prognosis Predictions Using Somatic Molecular Biomarkers. medRxiv : the preprint server for health sciences (2024)
Rachel D Harris, Olga A Taylor, Kimberly P Raghubar, Maria Monica J Gramatges, Mark C Zobeck, M Monica Gramatges, Karen R Rabin, Michael E Scheurer, Austin L Brown
Episodes of acute methotrexate-related neurotoxicity linked to compromised long-term neurocognitive function. Pediatric blood & cancer (2024)
Kirsty Hillier, Derek MacMath, Jessica Chumsky, Susan E Kirk, Candelaria O'Farrell, Taylor Olmsted Kim, Mark C Zobeck, Amanda B Grimes
Immunoglobulins act as predictors of chronicity in pediatric immune thrombocytopenia (ITP). Blood advances (2024)
Mark C Zobeck, Melanie Brooke Bernhardt, Kala Y Kamdar, Karen R Rabin, Philip J Lupo, Michael E Scheurer
Novel and replicated clinical and genetic risk factors for toxicity from high-dose methotrexate in pediatric acute lymphoblastic leukemia. Pharmacotherapy 43 (3) (2023)
Mark C Zobeck, Melanie Brooke Bernhardt, Kala Y Kamdar, Karen R Rabin, Philip J Lupo, Michael E Scheurer
Novel and replicated clinical and genetic risk factors for toxicity from high-dose methotrexate in pediatric acute lymphoblastic leukemia. Pharmacotherapy 43 (3) (2023)
David M Holmes, Apatsa Matatiyo, Atupele Mpasa, Minke H W Huibers, Geoffrey Manda, Tamiwe Tomoka, Maurice Mulenga, Ruth Namazzi, Parth Mehta, Mark C Zobeck, Rizine Mzikamanda, Murali Chintagumpala, Carl Allen, Jed G Nuchtern, Eric Borgstein, Daniel C Aronson, Nmazuo Ozuah, Bip Nandi, Casey L McAtee
Outcomes of Wilms tumor therapy in Lilongwe, Malawi, 2016-2021: Successes and ongoing research priorities. Pediatric blood & cancer 70 (5) (2023)
David M Holmes, Apatsa Matatiyo, Atupele Mpasa, Minke H W Huibers, Geoffrey Manda, Tamiwe Tomoka, Maurice Mulenga, Ruth Namazzi, Parth Mehta, Mark C Zobeck, Rizine Mzikamanda, Murali Chintagumpala, Carl Allen, Jed G Nuchtern, Eric Borgstein, Daniel C Aronson, Nmazuo Ozuah, Bip Nandi, Casey L McAtee
Outcomes of Wilms tumor therapy in Lilongwe, Malawi, 2016-2021: Successes and ongoing research priorities. Pediatric blood & cancer 70 (5) (2023)
Mark C Zobeck, Melanie Brooke Bernhardt, Kala Y Kamdar, Karen R Rabin, Philip J Lupo, Michael E Scheurer
Novel and replicated clinical and genetic risk factors for toxicity from high-dose methotrexate in pediatric acute lymphoblastic leukemia. Pharmacotherapy (2023)
David M Holmes, Apatsa Matatiyo, Atupele Mpasa, Minke H W Huibers, Geoffrey Manda, Tamiwe Tomoka, Maurice Mulenga, Ruth Namazzi, Parth Mehta, Mark C Zobeck, Rizine Mzikamanda, Murali Chintagumpala, Carl Allen, Jed G Nuchtern, Eric Borgstein, Daniel C Aronson, Nmazuo Ozuah, Bip Nandi, Casey L McAtee
Outcomes of Wilms tumor therapy in Lilongwe, Malawi, 2016-2021: Successes and ongoing research priorities. Pediatric blood & cancer (2023)
Mark C Zobeck, Melanie Brooke Bernhardt, Kala Y Kamdar, Karen R Rabin, Philip J Lupo, Michael E Scheurer
Novel and replicated clinical and genetic risk factors for toxicity from high-dose methotrexate in pediatric acute lymphoblastic leukemia. Pharmacotherapy 43 (3) (2023)
Mark C Zobeck, Melanie Brooke Bernhardt, Kala Y Kamdar, Karen R Rabin, Philip J Lupo, Michael E Scheurer
Novel and replicated clinical and genetic risk factors for toxicity from high-dose methotrexate in pediatric acute lymphoblastic leukemia. Pharmacotherapy (2023)
Zachary D Prudowsky, Kandice Bledsaw, Sharon Staton, Mark C Zobeck, Janet DeJean, Lindsay Johnson-Bishop, Anil P George, David H M Steffin, Alexandra M Stevens
Chlorhexidine gluconate (CHG) foam improves adherence, satisfaction, and maintains central line associated infection rates compared to CHG wipes in pediatric hematology-oncology and bone marrow transplant patients. Pediatric hematology and oncology (2022)
Mark C Zobeck, Melanie Brooke Bernhardt, Kala Y Kamdar, Karen R Rabin, Philip J Lupo, Michael E Scheurer
Novel risk factors for glucarpidase use in pediatric acute lymphoblastic leukemia: Hispanic ethnicity, age, and the ABCC4 gene. Pediatric blood & cancer 68 (8) (2021)